Nan-Horng Lin

发表

Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors.

Saul H. Rosenberg, Chang Park, P. Kovar, 2006, Bioorganic & medicinal chemistry letters.

Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics

Zhan Xiao, John Xue, Saul H Rosenberg, 2006, International journal of cancer.

Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors.

Saul H Rosenberg, Philip J. Merta, Gaoquan Li, 2007, Bioorganic & medicinal chemistry letters.

Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.

Chang Park, Philip J. Merta, Z. Tao, 2007, Journal of medicinal chemistry.

Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors.

Chang Park, Saul H Rosenberg, Gaoquan Li, 2006, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors.

Chang Park, John Xue, Saul H Rosenberg, 2007, Journal of medicinal chemistry.

Chk1 inhibitors for novel cancer treatment.

Z. Tao, N. Lin, Nan-Horng Lin, 2006, Anti-cancer agents in medicinal chemistry.

Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors.

Chang Park, Saul H Rosenberg, Y. Tong, 2007, Bioorganic & medicinal chemistry.

Efficient Total Syntheses of Pumiliotoxins A and B. Applications of Iodide-Promoted Iminium Ion−Alkyne Cyclizations in Alkaloid Construction

Leslie A. Robinson, Michael H. Rabinowitz, L. Overman, 1996 .